Comparison of Serotonin Glucuronidation Activity of UDP-glucuronosyltransferase 1a6a (Ugt1a6a) and Ugt1a6b: Evidence for the Preferential Expression of Ugt1a6a in the Mouse Brain

被引:10
|
作者
Uchihashi, Shinsuke [1 ]
Nishikawa, Miyu [1 ]
Sakaki, Toshiyuki [1 ]
Ikushiro, Shin-ichi [1 ]
机构
[1] Toyama Prefectural Univ, Dept Biotechnol, Fac Engn, Imizu, Toyama 9390398, Japan
关键词
UDP-glucuronosyl transferase (Ugt); Ugt1a6a; Ugt1a6b; serotonin; MESSENGER-RNA EXPRESSION; MICE; RAT; LIVER; 5-HYDROXYTRYPTAMINE; GENES; UGTS; METABOLISM; INDUCTION; ISOFORMS;
D O I
10.2133/dmpk.DMPK-12-NT-091
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mouse UDP-glucuronosyltransferase (Ugt) 1a6a and Ugt1a6b share 98% sequence homology, but there have been no reports to date that compare their expression levels or enzymatic activities in serotonin glucuronidation. Thus, we designed specific primers for Ugt1a6a and Ugt1a6b to compare their expression in mouse brain regions and livers. Ugt1a6a was dominantly expressed in mouse brains, especially the hippocampus, while both Ugt1a6a and Ugt1a6b were highly expressed in mouse livers, indicating that there are significant differences in the expression patterns of Ugt1a6a and Ugt1a6b among mouse tissues. Glucuronidation of endogenous neurotransmitter serotonin was catalyzed by Ugt1a6b with k(cat)/K-m (4.5 M-1.s(-1)) slightly higher than that of Ugt1a6a (2.4 M-1.s(-1)). However, the difference in expression levels between Ugt1a6a and Ugt1a6b in the hippocampus led us to speculate that Ugt1a6a is likely the predominant catalyst of serotonin glucuronidation in the mouse brain. In conclusion, we successfully elucidated the differences between Ugt1a6a and Ugt1a6b expression in the mouse brain. Our new findings indicate that Ugt1a6a and Ugt1a6b play different roles in mice, driven by differences in expression and kinetic properties for serotonin glucuronidation.
引用
收藏
页码:260 / 264
页数:5
相关论文
共 50 条
  • [21] Linkage disequilibrium of UGT1A1*6 and UGT1A1*28 in relation to UGT1A6 and UGT1A7 polymorphisms
    Urawa, Naohito
    Kobayashi, Yoshinao
    Araki, Jun
    Sugimoto, Ryosuke
    Iwasa, Motoh
    Kaito, Masahiko
    Adachi, Yukihko
    ONCOLOGY REPORTS, 2006, 16 (04) : 801 - 806
  • [22] Human UDP-Glucuronosyltransferase (UGT) 2B10 in Drug N-Glucuronidation: Substrate Screening and Comparison with UGT1A3 and UGT1A4
    Kato, Yukiko
    Izukawa, Takeshi
    Oda, Shingo
    Fukami, Tatsuki
    Finel, Moshe
    Yokoi, Tsuyoshi
    Nakajima, Miki
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (07) : 1389 - 1397
  • [23] Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6
    Krishnaswamy, S
    Duan, SX
    Von Moltke, LL
    Greenblatt, DJ
    Court, MH
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (01) : 133 - 139
  • [24] TCDD-inducible UDP-glucuronosyltranferases (UGT1A6 and UGT1A6) in human cells
    Lehmköster, T
    Heel, H
    Münzel, P
    Bock, KW
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R134 - R134
  • [25] Effects of β-Naphthoflavone on Ugt1a6 and Ugt1a7 Expression in Rat Brain
    Sakakibara, Yukiko
    Katoh, Miki
    Kondo, Yuya
    Nadai, Masayuki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (01) : 78 - 83
  • [26] Glucuronidation of odorant molecules in the rat olfactory system.: Activity, expression and age-linked modifications of UDP-glucuronosyltransferase isoforms, UGT1A6 and UGT2A1, and relation to mitral cell activity
    Leclerc, S
    Heydel, JM
    Amossé, V
    Gradinaru, D
    Cattarelli, M
    Artur, Y
    Goudonnet, H
    Magdalou, J
    Netter, P
    Pelczar, H
    Minn, A
    MOLECULAR BRAIN RESEARCH, 2002, 107 (02): : 201 - 213
  • [27] Effect of Genetic Polymorphisms in UDP-Glucuronosyltransferase 1A6 (UGT1A6) on Acetylsalicylic Acid Metabolism in Healthy Female Volunteers
    van Oijen, Martijn G. H.
    Barthelemy, Christine
    Janssen, Marcel J. R.
    Joiris, Etienne
    Peters, Wilbert H. M.
    Laheij, Robert J. F.
    Smits, Paul
    Odou, Pascal
    Jansen, Jan B. M. J.
    PHARMACOLOGY, 2009, 83 (04) : 237 - 242
  • [28] Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications
    Ciotti, M
    Marrone, A
    Potter, C
    Owens, IS
    PHARMACOGENETICS, 1997, 7 (06): : 485 - 495
  • [29] Renal Cell Carcinoma Treatment Drug Everolimus Inhibited UDP-Glucuronosyltransferase (UGT) 1A6
    Zhang, Xue-Feng
    Chen, Yun
    Wang, Jiang-Jun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (07): : 1284 - 1288
  • [30] Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7
    Antonio, L
    Xu, J
    Little, JM
    Burchell, B
    Magdalou, J
    Radominska-Pandya, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 411 (02) : 251 - 261